American College of Cardiology
Avatar

Trastuzumab Cardiotoxicity in mBC: When to Restart HER2 Therapy? Will Stopping Trastuzumab for 1 or 2 Administrations Impact the Patient Outcome?

By American College of Cardiology FEATURING Srilakshmi Vallabhaneni, Giuseppe Curigliano, Daniel Lenihan, Bonnie Ky
By American College of Cardiology FEATURING Srilakshmi Vallabhaneni, Giuseppe Curigliano, Daniel Lenihan, Bonnie Ky
49 views
September 21, 2020
Comments 0
Login to view comments. Click here to Login

Related Videos

17:12

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

1.5K views
15:19

Current Recommendations on Managing GI Adverse Reactions Associated …

Alberto Zambelli

946 views
26:06

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

618 views
05:59

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

323 views
20:41

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Cleveland Clinic Taussig Cancer Institute

R. Unwala

273 views
10:04

Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

184 views
14:27

Infectious Complications of Checkpoint Inhibitors: Discussing Overla…

Cleveland Clinic Taussig Cancer Institute

Z. Yetmar

212 views
53:42

Managing Women's Health in Menopause: Evolving Approaches for the Ma…

PleXus Communications

J. Simon, T. Iyer, A. Fiffick, M. Minkin

2.9K views
20:13

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

214 views
28:57

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

38 views
10:39

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

110 views
11:43

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

96 views
18:46

ESMO 2024 Insights: Current and Future Use of EGFR-Targeted Agents i…

2024 ESMO Annual Meeting Insights Hub

P. Garrido

144 views
11:59

How the Experts Manage: ADC-Associated Toxicities in NSCLC

MI&T Congressi

N. Leighl

171 views
15:54

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

670 views
07:40

Referral to Eye Care Provider for Management of Ocular Toxicity Asso…

Debra Richardson

103 views
15:01

WCLC 2024 Insights: Management of Radiation Toxicities in The Era of…

Insights from 2024 WCLC

P. Lee

93 views
19:28

Cutaneous Toxicity in Oncology: Mechanism and Management

OncoAlert

P. Bhargava

204 views
22:53

Pulmonary irAEs: Epidemiology, Diagnosis, and Treatment of ICI-P

Cleveland Clinic Taussig Cancer Institute

M. Smith

117 views
09:52

Managing Cardiotoxicities in BTKi Treatment for CLL: Atrial Fibrilla…

Lydia Scarfò

82 views
AUTOPLAY